| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $333.6M | +168.1% |
| Cost of Revenue | $50.6M | +184.1% |
| R&D Expense | $52.3M | +47.2% |
| SG&A Expense | $258.7M | +92.5% |
| Operating Income | -$27.9M | +55.8% |
| Pre-tax Income | -$38.9M | +40.7% |
| Income Tax | $266K | -51.4% |
| Net Income | -$39.1M | +40.8% |
| EPS (Basic) | -$0.17 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.9M | +202.4% |
| Accounts Receivable | $57.7M | +161.9% |
| Inventory | $91.2M | +84.3% |
| Current Assets | $356.5M | +44.8% |
| Total Assets | $435.8M | +46.4% |
| Current Liabilities | $77.8M | +54.4% |
| Long-term Debt | $150.9M | +202.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.8M | +50.1% |
| Capital Expenditures | $1.0M | +193.9% |
| Investing Cash Flow | -$18.3M | +86.0% |
| Financing Cash Flow | $106.6M | -27.1% |
| Free Cash Flow | -$45.8M | +49.1% |
| +43.3% |
| EPS (Diluted) | -$0.17 | +43.3% |
| Total Liabilities |
| $262.5M |
| +100.7% |
| Stockholders' Equity | $173.3M | +3.9% |